Monoclonal Mouse anti‑Human FBXO5 / EMI1 Antibody (clone FBXP5, Ready‑to‑Use, N‑Terminus, IHC, IF, WB) LS‑C391889
Monoclonal Mouse anti‑Human FBXO5 / EMI1 Antibody (clone FBXP5, Ready‑to‑Use, N‑Terminus, IHC, IF, WB) LS‑C391889
Antibody:
FBXO5 / EMI1 Mouse anti-Human Monoclonal (N-Terminus) (Ready-to-Use) (FBXP5) Antibody
Application:
IHC, IHC-P, IF, WB
Format:
Unconjugated, Ready-to-Use
Overview
Antibody:
FBXO5 / EMI1 Mouse anti-Human Monoclonal (N-Terminus) (Ready-to-Use) (FBXP5) Antibody
Application:
IHC, IHC-P, IF, WB
Format:
Unconjugated, Ready-to-Use
Specifications
Description
EMI1 antibody LS-C391889 is an unconjugated mouse monoclonal antibody to human EMI1 (FBXO5) (N-Terminus). Validated for IF, IHC and WB.
Target
Human FBXO5 / EMI1
Synonyms
FBXO5 | Early mitotic inhibitor 1 | F-box protein 5 | FBX5 | F-box protein Fbx5 | EMI1 | F-box only protein 5
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2a,k
Monoclonal
Conjugations
Unconjugated
Purification
Protein G purified
Modifications
Ready-to-Use.
Also available
Unmodified or
Azide-free, BSA-free.
Immunogen
Human partial recombinant N-Terminus protein fragment.
Specificity
Human FBXO5 / EMI1
Applications
- IHC
- IHC - Paraffin (1:1)
- Immunofluorescence
- Western blot
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. Early Mitotic Inhibitor-1 regulates mitosis by inhibiting the anaphase promoting complex/cyclosome (APC). It is a conserved F box protein containing a zinc-binding region essential for APC inhibition. The protein functions to promote cyclin A accumulation and S phase entry in somatic cells by inhibiting the APC complex. At the G1-S transition, EMI-1 is transcriptionally induced by the E2F transcription factor. Overexpression accelerates S-phase entry and can override a G1 block caused by overexpression of Cdh1 or the E2F-inhibitor p105 retinoblastoma protein (pRb). Depleting cells of EMI-1 through RNA interference prevents accumulation of cyclin A and inhibits S phase entry. Optimal dilution of the EMI-1 antibody should be determined by the researcher. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate buffer, pH 6.0 for 10-20 min followed by cooling at RT for 20 minutes. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Presentation
1X PBS, 0.1 mg/ml BSA, 0.05% sodium azide
Storage
Store at 2°C to 8°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot
Species:
Human
Applications:
Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 2/12/2025